- Home
- ZLAB vs CUBI Comparison
ZLAB vs CUBI Comparison
Compare ZLAB & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | CUBI |
|---|---|---|
| Founded | 2013 | 1994 |
| Country | China | United States |
| Employees | N/A | 790 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.4B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZLAB | CUBI |
|---|---|---|
| Price | $18.54 | $66.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | $49.44 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 536.1K | 381.2K |
| Earning Date | 05-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $460,156,000.00 | N/A |
| Revenue This Year | $14.46 | $25.24 |
| Revenue Next Year | $29.47 | $9.30 |
| P/E Ratio | ★ N/A | $11.78 |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $40.75 |
| 52 Week High | $44.34 | $82.56 |
Technical Indicators
Market Signals| Indicator | ZLAB | CUBI |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 35.72 |
| Support Level | $16.77 | $64.84 |
| Resistance Level | $19.70 | $68.28 |
| Average True Range (ATR) | 0.75 | 2.66 |
| MACD | -0.10 | -0.25 |
| Stochastic Oscillator | 44.37 | 26.02 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.